Informed-money record

VERA · Vera Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$348K + 3 of unknown size / $18.5M + 2 of unknown size

Recent disclosures

25 of 48 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-09-15	PRESIDENT AND CEO Fordyce Marshall	sold	$685K	SEC ↗
2026-09-11	SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R	exercised options & held the shares	$20K	SEC ↗
2026-09-02	PRESIDENT AND CEO Fordyce Marshall	sold	$650K	SEC ↗
2026-09-02	Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MARSHALL FORDYCE	filed notice to sell	$2.2M	SEC ↗
2026-08-14	5%+ holder (13G) — reduced stake Kynam Capital Management, LP	reduced its stake (13D/G amendment)	—	SEC ↗

23 more disclosures in the window — the full record, scoring, and track-record evidence are for members.

Want the read, not just the record?

Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals